RSS-Feed abonnieren
DOI: 10.1055/s-0038-1651092
Effect of the Polyamine-Spermine on Agonist-Induced Human Platelet Activation - Specific Inhibition of "Aggregation-Independent" Events Induced by Thrombin, but not by Collagen, Thromboxane Mimetic, Phorbol Ester or Calcium lonophore
Publikationsverlauf
Received 08. Oktober 1986
Accepted after revision 08. Januar 1987
Publikationsdatum:
28. Juni 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/198702/lookinside/thumbnails/10-1055-s-0038-1651092-1.jpg)
Summary
Spermine, a naturally occurring polyamine, has previously been described as an inhibitor of purified phospholipase C and protein kinase C in cell-free systems. The present study examines the effect of spermine on platelet aggregation, dense-granule secretion and thromboxane (Tx) B2 synthesis induced by a variety of agonists, which cause the activation of one or both enzymes to different extents. These studies revealed that, while spermine (10 mM) inhibited platelet aggregation in response to all the agonists examined, [14C]-5-hydroxytryptamine (5HT) release and TxB2 synthesis induced by thrombin (0.2 U/ml) and collagen (10-40 μg/ml) alone, were inhibited by spermine, the percentage inhibition being >90% for both responses with thrombin, 30% for 5HT release and 80% for TxB2 synthesis with collagen. The inhibition of collagen-induced [14C]-5HT secretion by spermine was due entirely to the inhibition of aggregation-dependent TxA2 synthesis as addition of a sub-threshold concentration of U46619, which induced no secretion on its own, totally restored collagen-induced [14C]-5HT secretion to the levels seen in the absence of spermine. Moreover, collagen-induced TxB2 formation in unstirred platelets, which occurred independently of aggregation was not significantly affected by spermine (10 mM). However, the inhibition of maximal thrombin-induced [14C]-5HT secretion and TxB2 synthesis, which are both aggregation-independent phenomena, could be attributed to the inhibition of thrombin-induced diacylglycerol formation and intracellular calcium mobilization, which were both inhibited by 80% in the presence of spermine. These results suggest that spermine may be a specific inhibitor of thrombin-induced platelet responses rather than a generally effective inhibitor of platelet phospholipase C and protein kinase C or the activation of these enzymes in response to agpnists other than thrombin, at least when added exogenously to intact platelets. This thrombin-specific inhibition may be due to an interference of the binding of thrombin to its platelet receptor and/or interference at a step following thrombin binding, which is involved in the subsequent coupling processes.
-
References
- 1 Berridge MJ. Inositol trisphosphate and diacylglycerol as second messengers. Biochem J 1984; 220: 345-360
- 2 Hokin L. Receptors and phosphoinositide-generated second messengers. Ann Rev Biochem 1985; 54: 205-235
- 3 Majerus PW, Wilson DB, Connolly TM, Bross TE, Neufeld EJ. Phosphoinositide turnover provides a link in stimulus-response coupling. Trends Biochem Sci 1985; 10: 168-170
- 4 Brass LF, Joseph SK. A role for inositol trisphosphate in intracellular Ca2+mobilization and granule secretion in platelets. J Biol Chem 1985; 260: 15172-15179
- 5 Authi KS, Evenden BJ, Crawford N. Metabolic and functional consequences of introducing inositol 1,4,5-trisphosphate into saponin-permeabilized human platelets. Biochem J 1985; 233: 709-718
- 6 Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984; 308: 693-698
- 7 Rink TJ, Sanchez A, Hallam TJ. Diacylglycerol and phorbol ester stimulates secretion without raising cytoplasmic free calcium in human platelets. Nature 1983; 305: 317-319
- 8 Pegg AE, McCann PP. Polyamine metabolism and function. Amer J Physiol 1982; 243: C212-C20
- 9 Abraham KA, Pihl A. Role of polyamines in macromolecular synthesis. Trends Biochem Sci 1981; 6: 106-107
- 10 Nahas N, Graff G. Inhibitory effect of polyamines on phospholipase C from human platelets. Biochem Biophys Res Commun 1982; 109: 1035-1040
- 11 Qi D, Schatzmann RC, Mazzei GT, Turner RS, Rayner RL, Liao S, Fuo JF. Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases. Biochem J 1983; 213: 218-258
- 12 Sechi AM, Gabrini L, Landi L, Pasquali P, Lenaz G. Inhibition of phospholipase A2and phospholipase C by polyamines. Arch Biochem Biophys 1978; 186: 248-254
- 13 Agam G, Gartner TK, Livne A. Inhibition of platelet aggregation and endogenous lectin activity by oligoamines. Thromb Res 1984; 33: 245-257
- 14 Ganguly P, Bradford HR. Inhibition of platelet aggregation by primary amines. Evidence for a possible role of membrane-associated calcium. Biochem Biophys Acta 1982; 714: 192-199
- 15 Holub BJ. Altered phospholipid metabolism in thrombin-stimulated human platelets. Can J Biochem Cell Biol 1984; 62: 341-350
- 16 Rittenhouse SE, Allen CL. Production of diglyceride from phosphatidylinositol in activated human platelets. J Clin Invest 1982; 70: 1216-1224
- 17 Rittenhouse SE. Activation of human platelet phospholipase C by ionophore A23187 is totally dependent upon cyclo-oxygenase products and ADP. Biochem J 1984; 222: 103-110
- 18 Pollock WK, Armstrong RA, Brydon LJ, Jones RL, MacIntyre DE. Thromboxane-induced phosphatidate formation in human platelets. Relationship to receptor occupancy and to changes in cytosolic free calcium Biochem J 1984; 219: 833-842
- 19 Joseph SK, Krishnamurthi S. Effect of the polyamine spermine on human platelet activation. Thromb Haemostas 1985; 54: 135 (Abstr)
- 20 Krishnamurthi S, Westwick J, Kakkar VV. Effect of pyridoxal 5’-phosphate (PALP) on human platelet aggregation, dense-granule release and thromboxane B2generation - role of Schiff base formation. Thromb Haemostas 1982; 48: 136-141
- 21 Murer EH. The role of platelet calcium. Semin Hematol 1985; 22: 313-323
- 22 Rink TJ, Pozzan T. Using quin 2 in cell suspensions. Cell Calcium 1985; 6: 133-144
- 23 Bills TK, Smith JB, Silver MJ. Metabolism of 14C-arachidonic acid by human platelets. Biochem Biophys Acta 1976; 424: 303-314
- 24 Beil RL, Kennedy DA, Standford N, Majerus PW. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci 1979; 76: 3238-3241
- 25 Krishnamurthi S, Westwick J, Kakkar VV. Regulation of human platelet activation - analysis of cyclooxygenase and cyclic AMP-dependent pathways. Biochem Pharmacol 1984; 33: 3025-3035
- 26 Detwiler TC, Huang EM. The interrelationship of platelet aggregation, secretion and prostaglandin synthesis. In The Regulation of Coagulation. Mann KG, Taylor FB. (eds). pp 377-383 Elsevier; New York, Amsterdam: 1980
- 27 Nadler SG, Takahashi MT. Putrescine transport in human platelets. Biochem Biophys Acta 1985; 812: 345-352
- 28 Knight DE, Scrutton MC. Gaining access to the cytosol: the technique and some applications of electropermeabilization. Biochem J 1986; 234: 497-506
- 29 Vergara J, Tsien RY, Delay M. Inositol 1,4,5-trisphosphate: a possible chemical link in excitation-contraction coupling in muscle. Proc Natl Acad Sci USA 1985; 82: 6352-6356
- 30 Peerschke E IB. The platelet fibrinogen receptor. Semin Hematol 1985; 22: 241-259
- 31 Gartner TK, Gerrard JM, White JG, Williams DC. Fibrinogen is the receptor for the endogenous lectin of human platelets. Nature 1981; 289: 263-269
- 32 Kinlough-Rathbone RL, Packham MA, Mustard JF. Effects of amino-sugars on platelet aggregation and fibrinogen binding. Thromb Haemost 1984; 52: 75-80